<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04636567</url>
  </required_header>
  <id_info>
    <org_study_id>LICOR-10417-04</org_study_id>
    <nct_id>NCT04636567</nct_id>
  </id_info>
  <brief_title>Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery</brief_title>
  <official_title>A Phase 2 Open-label Study to Evaluate the Use of Nerindocianine as a Surgical Aid in the Delineation of Abdominopelvic Ureter Anatomy Via Near-infrared Fluorescence Imaging in the Setting of Minimally Invasive Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Li-Cor, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Li-Cor, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase 2, multicenter, efficacy and safety study evaluating the use of nerindocianine for the&#xD;
      delineation of abdominopelvic ureter anatomy via near infrared fluorescence imaging during&#xD;
      minimally invasive lower abdominal surgery (e.g. gynecological, lower gastrointestinal, or&#xD;
      other lower abdominal surgery).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to assess the acceptance of near-infrared (NIR)&#xD;
      fluorescence imaging (650 to 900 nm) compared to white light (WL) using 3 3-point Likert&#xD;
      scales.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Clinical program has been suspended for business reasons.&#xD;
  </why_stopped>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of ureter delineation using a Likert scale to measure ureter visualization</measure>
    <time_frame>Surgical procedure duration, estimated up to 5 hours</time_frame>
    <description>Evaluation of the pelvic ureter under WL and NIR illumination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment-Emergent Adverse Events</measure>
    <time_frame>30 +/- 5 days</time_frame>
    <description>Incidence of Treatment-Emergent Serious Adverse Events and/or Treatment-Emergent Adverse Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hourly time point scores concurrence with video review</measure>
    <time_frame>Scoring occurs at 1-hour intervals for duration of surgical procedure (estimated duration from 1 to 5 hours)</time_frame>
    <description>Three 3-pt Likert scale scores at hourly time points during the procedure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Intraoperative Ureter Injury</condition>
  <arm_group>
    <arm_group_label>Nerindocianine for injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One Arm: Nerindocianine for Injection (0.055 mg/kg body weight); solution, intravenous, one time administration during surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nerindocianine for injection</intervention_name>
    <description>Procedure: routine minimally invasive abdominopelvic surgery.</description>
    <arm_group_label>Nerindocianine for injection</arm_group_label>
    <other_name>IRDye 800BK</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provide written informed consent prior to the initiation of study procedures.&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
          -  Consent to undergo minimally invasive, lower pelvic surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling or unable to provide informed consent.&#xD;
&#xD;
          -  Unwilling or unable to comply with the requirements of the protocol.&#xD;
&#xD;
          -  Females who are pregnant, lactating, or planning a pregnancy throughout the study.&#xD;
&#xD;
          -  Patients administered indocyanine green (ICG) at the same time of the lower pelvic&#xD;
             surgery.&#xD;
&#xD;
          -  Have known allergies to D-mannitol and/or citric acid.&#xD;
&#xD;
          -  Participation in another clinical trial involving a drug in the past 12 weeks.&#xD;
&#xD;
          -  Any other condition that, in the investigator's judgment, would potentially compromise&#xD;
             the study compliance or the ability to evaluate safety or efficacy of the&#xD;
             investigational product, or determined not a safe candidate for surgery based on&#xD;
             standard of care for current medical condition.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanna Da Silva Southwich, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jubilee Brown, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolinas Medical Center / Levine Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center/Levine Cancer Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2020</study_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>contrast agent</keyword>
  <keyword>intraoperative monitoring</keyword>
  <keyword>intraoperative procedures</keyword>
  <keyword>near infrared fluorescence</keyword>
  <keyword>minimally invasive</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data (IPD) available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

